Suppr超能文献

体内受体结合定量分析。I. 理论及其在毒蕈碱型胆碱能受体中的应用

Quantitative in vivo receptor binding. I. Theory and application to the muscarinic cholinergic receptor.

作者信息

Frey K A, Ehrenkaufer R L, Beaucage S, Agranoff B W

出版信息

J Neurosci. 1985 Feb;5(2):421-8. doi: 10.1523/JNEUROSCI.05-02-00421.1985.

Abstract

A novel approach to in vivo receptor binding experiments is presented which allows direct quantitation of binding site densities. The method is based on an equilibrium model of tracer uptake and is designed to produce a static distribution proportional to receptor density and to minimize possible confounding influences of regional blood flow, blood-brain barrier permeability, and nonspecific binding. This technique was applied to the measurement of regional muscarinic cholinergic receptor densities in rat brain using [3H]scopolamine. Specific in vivo binding of scopolamine demonstrated saturability, a pharmacologic profile, and regional densities which are consistent with interaction of the tracer with the muscarinic receptor. Estimates of receptor density obtained with the in vivo method and in vitro measurements in homogenates were highly correlated. Furthermore, reduction in striatal muscarinic receptors following ibotenic acid lesions resulted in a significant decrease in tracer uptake in vivo, indicating that the correlation between scopolamine distribution and receptor density may be used to demonstrate pathologic conditions. We propose that the general method presented here is directly applicable to investigation of high affinity binding sites for a variety of radioligands.

摘要

本文提出了一种用于体内受体结合实验的新方法,该方法可直接定量结合位点密度。该方法基于示踪剂摄取的平衡模型,旨在产生与受体密度成比例的静态分布,并最大限度地减少区域血流、血脑屏障通透性和非特异性结合等可能的混杂影响。使用[3H]东莨菪碱将该技术应用于大鼠脑内毒蕈碱胆碱能受体密度的测量。东莨菪碱的特异性体内结合表现出饱和性、药理学特征以及与示踪剂与毒蕈碱受体相互作用一致的区域密度。通过体内方法获得的受体密度估计值与匀浆中的体外测量值高度相关。此外,鹅膏蕈氨酸损伤后纹状体毒蕈碱受体的减少导致体内示踪剂摄取显著降低,这表明东莨菪碱分布与受体密度之间的相关性可用于证明病理状况。我们认为,本文提出的通用方法可直接应用于研究多种放射性配体的高亲和力结合位点。

相似文献

1
Quantitative in vivo receptor binding. I. Theory and application to the muscarinic cholinergic receptor.
J Neurosci. 1985 Feb;5(2):421-8. doi: 10.1523/JNEUROSCI.05-02-00421.1985.
2
Quantitative in vivo receptor binding III: Tracer kinetic modeling of muscarinic cholinergic receptor binding.
Proc Natl Acad Sci U S A. 1985 Oct;82(19):6711-5. doi: 10.1073/pnas.82.19.6711.
3
Quantitative in vivo receptor binding. II. Autoradiographic imaging of muscarinic cholinergic receptors.
J Neurosci. 1985 Sep;5(9):2407-14. doi: 10.1523/JNEUROSCI.05-09-02407.1985.
5
Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
Brain Res. 1986 Jan 8;362(2):239-53. doi: 10.1016/0006-8993(86)90449-x.

引用本文的文献

2
Renal and extrarenal effects of fibroblast growth factor 23.
Nat Rev Nephrol. 2019 Feb;15(2):109-120. doi: 10.1038/s41581-018-0087-2.
4
Kinetic analysis of the metabotropic glutamate subtype 5 tracer [(18)F]FPEB in bolus and bolus-plus-constant-infusion studies in humans.
J Cereb Blood Flow Metab. 2013 Apr;33(4):532-41. doi: 10.1038/jcbfm.2012.195. Epub 2012 Dec 19.
5
Hippocampal M1 receptor function associated with spatial learning and memory in aged female rhesus macaques.
Age (Dordr). 2011 Sep;33(3):309-20. doi: 10.1007/s11357-010-9184-2. Epub 2010 Oct 2.
6
The cholinergic system and Parkinson disease.
Behav Brain Res. 2011 Aug 10;221(2):564-73. doi: 10.1016/j.bbr.2009.12.048. Epub 2010 Jan 7.
7
Imaging of cholinergic and monoaminergic neurochemical changes in neurodegenerative disorders.
Mol Imaging Biol. 2007 Jul-Aug;9(4):243-57. doi: 10.1007/s11307-007-0083-6.
8
Quantitative in vivo receptor binding III: Tracer kinetic modeling of muscarinic cholinergic receptor binding.
Proc Natl Acad Sci U S A. 1985 Oct;82(19):6711-5. doi: 10.1073/pnas.82.19.6711.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验